A phase 2 study of zanubrutinib in previously treated B‐cell malignancies intolerant to ibrutinib and/or acalabrutinib: Preliminary results for patients with CLL/SLL
Shadman, M., Burke, J. M., Zafar, S. F., Misleh, J., Rao, S. S., Farber, C. M., Cohen, A., Crescenzo, R., By, K., Flinn, I. W., Sharman, J. P.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
CIRCULATING TUMOR DNA (CTDNA) STATUS AND CLINICAL OUTCOMES IN PATIENTS (PTS) WITH PREVIOUSLY UNTREATED DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) IN THE POLARIX STUDY
Herrera, A. F., Tracy, S., Sehn, L. H., Jardin, F., Lenz, G., Trněný, M., Salles, G., Flowers, C. R., Tilly, H., Sharman, J. P., Friedberg, J. W., Balasubramanian, S., Raghavan, V., Hirata, J., Lee, C., Jiang, Y., Morschhauser, F.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
PRELIMINARY RESULTS OF THE PHASE 2 STUDY OF ZANUBRUTINIB IN PATIENTS WITH PREVIOUSLY TREATED B‐CELL MALIGNANCIES INTOLERANT TO IBRUTINIB AND/OR ACALABRUTINIB
Shadman, M., Sharman, J. P., Levy, M. Y., Porter, R., Zafar, S. F., Burke, J. M., Chaudhry, A., Freeman, B., Misleh, J., Yimer, H. A., Cultrera, J. L., Guthrie, T. H., Kingsley, E., Rao, S. S., Chen, D. Y., Zhang, X., Idoine, A., Cohen, A., Feng, S., Huang, J., Flinn, I.
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article
PB1864: BRUIN CLL‐321: A PHASE 3 OPEN‐LABEL, RANDOMIZED STUDY OF PIRTOBRUTINIB VS INVESTIGATOR'S CHOICE OF IDELALISIB+RITUXIMAB OR BENDAMUSTINE+RITUXIMAB IN BTKI PRETREATED CLL/SLL (TRIAL IN PROGRESS)
Sharman, J. P., Jurczak, W., Coombs, C. C., Hill, M., Wang, D., Ku, N. C., Guntur, A., Shahda, S., Leow, C. C., Ghia, P., Mato, A. R.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
Vemurafenib Response in 2 Patients With Posttransplant Refractory BRAF V600E–Mutated Multiple Myeloma
Sharman, J.P, Chmielecki, J, Morosini, D, Palmer, G.A, Ross, J.S, Stephens, P.J, Stafl, J, Miller, V.A, Ali, S.M
Published in Clinical lymphoma, myeloma and leukemia (01.10.2014)
Published in Clinical lymphoma, myeloma and leukemia (01.10.2014)
Get full text
Journal Article
P1156: MAGNIFY PHASE 3B STUDY OF LENALIDOMIDE + RITUXIMAB (R2) FOLLOWED BY MAINTENANCE IN RELAPSED/REFRACTORY INDOLENT NON‐HODGKIN LYMPHOMA: COMPLETE INDUCTION PHASE ANALYSIS
Lansigan, F., Andorsky, D. J., Coleman, M., Yacoub, A., Melear, J. M., Fanning, S. R., Kolibaba, K. S., Reynolds, C., Nowakowski, G. S., Gharibo, M., Ahn, J. R., Li, J., Rummel, M. J., Sharman, J. P.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
P1100: BRUIN MCL‐321: A PHASE 3 OPEN‐LABEL, RANDOMIZED STUDY OF PIRTOBRUTINIB VS INVESTIGATOR CHOICE OF BTK INHIBITOR IN PATIENTS WITH PREVIOUSLY TREATED, BTK INHIBITOR NAÏVE MCL (TRIAL IN PROGRESS)
Eyre, T. A., Shah, N. N., Le Gouill, S., Dreyling, M., Vandenberghe, E., Jurczak, W., Wang, Y., Cheah, C. Y., Gandhi, M., Chay, C., Sharman, J. P., Andorsky, D. J., Yin, M., Balbas, M., Kherani, J., Wang, M. L.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
PB1890: ZANUBRUTINIB IN ACALABRUTINIB‐INTOLERANT PATIENTS (PTS) WITH B‐CELL MALIGNANCIES
Shadman, M., Flinn, I. W., Kingsley, E. C., Freeman, B., Levy, M. Y., Cultrera, J., Farber, C. M., Chaudhry, A., Porter, R., Crescenzo, R., Idoine, A., Zhang, X., Cohen, A., By, K., Huang, J., Sharman, J. P.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
P1192: ASIA SUBPOPULATION ANALYSIS FROM THE PHASE III POLARIX TRIAL
Song, Y., Jin, J., Tilly, H., Zhang, H., Cao, J., Feng, J., Zhang, L., Rai, S., Goto, H., Terui, Y., Kim, W. S., Shin, H.‐J., Gau, J.‐P., Tsai, C.‐H., Sharman, J. P., Bu, L., Hirata, J., Lee, C., Izutsu, K., Zhu, J.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
P666: ACALABRUTINIB ± OBINUTUZUMAB VS OBINUTUZUMAB + CHLORAMBUCIL IN TREATMENT‐NAIVE CHRONIC LYMPHOCYTIC LEUKEMIA: 5‐YEAR FOLLOW‐UP OF ELEVATE‐TN
Sharman, J. P., Egyed, M., Jurczak, W., Skarbnik, A., Patel, K., Flinn, I. W., Kamdar, M., Munir, T., Walewska, R., Fogliatto, L. M., Herishanu, Y., Banerji, V., Follows, G., Walker, P., Karlsson, K., Ghia, P., Janssens, A., Cymbalista, F., Ferrant, E., Wierda, W. G., Munugalavadla, V., Yu, T., Wang, M. H., Woyach, J. A.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article
P1101: PIRTOBRUTINIB, A HIGHLY SELECTIVE, NON‐COVALENT (REVERSIBLE) BTK INHIBITOR IN PREVIOUSLY TREATED MANTLE CELL LYMPHOMA: UPDATED RESULTS FROM THE PHASE 1/2 BRUIN STUDY
Eyre, T. A., Wang, M. L., Shah, N. N., Alencar, A. J., Gerson, J. N., Patel, M. R., Fakhri, B., Vandenberghe, E., Jurczak, W., Tan, X. N., Lewis, K. L., Fenske, T., Wang, Y., Coombs, C. C., Flinn, I., Lewis, D., Le Gouill, S., Gandhi, M., Chay, C., Palomba, M. L., Woyach, J. A., Pagel, J. M., Lamanna, N., Sharman, J. P., Andorsky, D. J., Cohen, J. B., Barve, M. A., Ghia, P., Yin, M., Zinzani, P. L., Ujjani, C., Koh, Y., Izutsu, K., Lech‐Maranda, E., Kherani, J., Tam, C., Sundaram, S., Nair, B., Tsai, D. E., Balbas, M., Mato, A. R., Cheah, C. Y.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
INDUCTION R2 FOLLOWED BY MAINTENANCE IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: INTERIM ANALYSIS FROM THE PHASE 3B MAGNIFY STUDY
Sharman, JP, Melear, JM, Yacoub, A, Fanning, SR, Andorsky, DJ, Nowakowski, GS, Rummel, MJ, Lansigan, F, Li, J, Ahn, JR, Gharibo, M, Coleman, M
Published in Hematology, Transfusion and Cell Therapy (01.10.2021)
Published in Hematology, Transfusion and Cell Therapy (01.10.2021)
Get full text
Journal Article
SUBGROUP ANALYSES OF ELDERLY PATIENTS AGED 70 YEARS IN MAGNIFY: A PHASE 3B INTERIM ANALYSIS OF INDUCTION R2 FOLLOWED BY MAINTENANCE IN RELAPSED/REFRACTORY INDOLENT NON-HODGKIN LYMPHOMA
Lansigan, F, Andorsky, DJ, Coleman, M, Yacoub, A, Md, JMM, Fanning, SR, Kolibaba, KS, Reynolds, C, Nowakowski, G, Gharibo, M, Ahn, E, Li, J, Rummel, MJ, Sharman, JP
Published in Hematology, Transfusion and Cell Therapy (01.10.2021)
Published in Hematology, Transfusion and Cell Therapy (01.10.2021)
Get full text
Journal Article
PATIENTS WITH RELAPSED/REFRACTORY MARGINAL ZONE LYMPHOMA IN THE MAGNIFY PHASE 3B INTERIM ANALYSIS OF INDUCTION R2 FOLLOWED BY MAINTENANCE
Coleman, M, Andorsky, DJ, Yacoub, A, Melear, JM, Fanning, SR, Kolibaba, KS, Lansigan, F, Reynolds, C, Nowakowski, G, Gharibo, M, Ahn, E, Li, J, Rummel, MJ, Sharman, JP
Published in Hematology, Transfusion and Cell Therapy (01.10.2021)
Published in Hematology, Transfusion and Cell Therapy (01.10.2021)
Get full text
Journal Article
Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma
Tilly, Hervé, Morschhauser, Franck, Sehn, Laurie H, Friedberg, Jonathan W, Trněný, Marek, Sharman, Jeff P, Herbaux, Charles, Burke, John M, Matasar, Matthew, Rai, Shinya, Izutsu, Koji, Mehta-Shah, Neha, Oberic, Lucie, Chauchet, Adrien, Jurczak, Wojciech, Song, Yuqin, Greil, Richard, Mykhalska, Larysa, Bergua-Burgués, Juan M, Cheung, Matthew C, Pinto, Antonio, Shin, Ho-Jin, Hapgood, Greg, Munhoz, Eduardo, Abrisqueta, Pau, Gau, Jyh-Pyng, Hirata, Jamie, Jiang, Yanwen, Yan, Mark, Lee, Calvin, Flowers, Christopher R, Salles, Gilles
Published in The New England journal of medicine (27.01.2022)
Published in The New England journal of medicine (27.01.2022)
Get full text
Journal Article
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023
Shadman, M, Burke, J M, Zafar, S F, Misleh, J, Rao, S S, Farber, C M, Cohen, A, Crescenzo, R, By, K, Flinn, I W, Sharman, J P
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
Phase I study of single-agent CC-292, a highly selective Bruton's tyrosine kinase inhibitor, in relapsed/refractory chronic lymphocytic leukemia
Brown, Jennifer R, Harb, Wael A, Hill, Brian T, Gabrilove, Janice, Sharman, Jeff P, Schreeder, Marshall T, Barr, Paul M, Foran, James M, Miller, Thomas P, Burger, Jan A, Kelly, Kevin R, Mahadevan, Daruka, Ma, Shuo, Li, Yan, Pierce, Daniel W, Barnett, Evelyn, Marine, Jeffrey, Miranda, Monika, Azaryan, Ada, Yu, Xujie, Nava-Parada, Pilar, Mei, Jay, Kipps, Thomas J
Published in Haematologica (Roma) (01.07.2016)
Published in Haematologica (Roma) (01.07.2016)
Get full text
Journal Article
INDUCTION R 2 FOLLOWED BY MAINTENANCE IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: INTERIM ANALYSIS FROM THE PHASE 3B MAGNIFY STUDY
Sharman, J. P., Melear, J. M., Yacoub, A., Fanning, S. R., Andorsky, D. J., Nowakowski, G. S., Rummel, M. J., Lansigan, F., Li, J., Ahn, J. R., Gharibo, M., Coleman, M.
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article
INDUCTION R 2 FOLLOWED BY MAINTENANCE IN PATIENTS WITH RELAPSED/REFRACTORY TRANSFORMED FOLLICULAR LYMPHOMA: INTERIM ANALYSIS FROM THE PHASE 3B MAGNIFY STUDY
. Lansigan, F, . Parameswaran, V, . Yacoub, A, . Reynolds, C. M, . Shao, S. H, . Moore, S. G, . Coleman, M, . Andorsky, D. J, . Nowakowski, G. S, . Rummel, M. J, . Li, J, . Ahn, J. R, . Gharibo, M, . Sharman, J. P
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article